$NWBO I get all alerts for DCVAX, first time ever I got a alert of Reuters, The I/B/E/S Buy rating of Outperform posted yesterday, Reuters for NWBO comes from financial data associated with LSEG, London Stock Exchange Group. Most all of my alerts come from news like in the 3rd image attached. Probably nothing but noted anyway.

$NWBO @NorthwestBio As we now head into the weekend and November nears we now know via the CHM minutes for August 2026 "A medicine used to treat glioblastoma cancer of the brain" was mentioned in the Pre-Hearing section indicating an Oral meeting will be needed to decide whether the data have resolved the questions put to the NorthWest Bio. Based on history and language used in past CHM minutes, specifically in May of 2024 where Eli Lilly was informed for an Oral meeting and then in July the meeting was held resulting in a decision and approval in August of 2024 two months after the Pre-Hearing paragraph on the alzheimer's drug. Will DCVAX-L follow the same timelines ? That is the question or will MHRA ask for even more answers that can't be resolved in meeting. We do not know for sure Oral meeting happened in Sept, but if it did, OCT meeting should be the decision and possible approval for Nov 2026. These are all if's but I believe the timelines are feasable and just maybe we are at the END of the ROAD.

$NWBO I had AI go through all my CHM Meeting files from 2023-2026 looking for comparisons of this statement in every CHM meeting file "The Commission advised that the concerns had not been adequately addressed and the applicants should be invited to address these concerns in oral representations to the Commission." Attached are my findings , had 2 oral request in 2023, 5 in 2024, 2 in 2025 and ours in 2026. This information is the best I could come with with based on what CHM meetings release to the public and trying to piece together what was approved afterwards.

$NWBO It would be reasonable to question why NHSBT would devote specialist capabilities to DCVax-L if the project had no credible future. NHSBT publicly announced its collaboration with NWBO and Advent Bioservices. The agreement includes: Leukapheresis collection of patients' immune cells. Specialist cell processing and handling. Initial operations in Leeds and Oxford. Exploration of expansion to other locations across England. In regards to CHM meeting notes for August 2026

$NWBO August CHM Meeting Posted app.box.com/s/jv487awvqzzsrd… PRE–HEARING (The Commission considers the company’s written data a month before the potential oral hearing and decides whether the data have resolved the questions put to the company) "A medicine used to treat glioblastoma (a cancer of the brain)."

Interesting CSTI setup a ask wall for 370K shares at .1650 at close. Usually we get bumped down at close.

$nwbo So as of 2:45pm we sit at 5.7 Million in Volume, all the 400 block trading yesterday does not exist today, back to the usual activity, large buys and very large sells which I believe is the increase in Outstanding Shares. As you see here just from a technical analysis we need to break and close above .18 cents. In the scheme of things current share price means nothing except for Day Traders, although it does cost more to keep the lights on as SP decreases. We continue to have long term holders borrow out their shares which makes them money but helps the shorts, which makes no sense to me, just my opinion. The day of reckoning will come for the Shorts when I believe the MHRA decesion happens and the odds are high it will be approved.

$NWBO News continues to spread in the Digital Media. scientistlive.com/partnershi…